𝔖 Bobbio Scriptorium

✦ LIBER ✦

Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy

✍ Scribed by Lee, Soo-Youn; Im, Seock-Ah; Park, Yeon Hee; Woo, Sook Young; Kim, Seonwoo; Choi, Moon Ki; Chang, Wonjin; Ahn, Jin Seok; Im, Young-Hyuck

Book ID: 121451723
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 919 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2013.11.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HER2/CEP17 ratio and HER2 immunohistoche

HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer

✍ Ji-Won Kim, Jee Hyun Kim, Seock-Ah Im, Yu Jung Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 261 KB

Evaluating health-related quality-of-lif

Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer

✍ Carol M. Moinpour, Gary W. Donaldson, Astra M. Liepa, Allen S. Melemed, Joyce O’ 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 392 KB